SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
10-May-24 6:09 PM View: | Theravance Biopharma, Inc. (TBPH) | 08-May-24 | Grant | 10,537 | -- | -- | 15% 70.02K to 80.56K | |
18-Mar-24 6:14 PM View: | Precigen, Inc. (PGEN) | 14-Mar-24 | Grant | 39,510 | $1.43 | $56,499.30 | 9% 463.67K to 503.18K | |
12-Mar-24 7:54 PM View: | Precigen, Inc. (PGEN) | 09-Mar-24 | Option Exercise | 106,837 | -- | -- | 30% 356.84K to 463.67K | |
12-Feb-24 4:48 PM View: | Immunogen Inc. (IMGN) | 12-Feb-24 | Disposition | 103,000 | -- | -- | (100%) 103.0K to 0 | |
26-Sep-23 4:08 PM View: | Immunogen Inc. (IMGN) | 22-Sep-23 | Option Exercise | 10,000 | $14.70 | $147,000.00 | 7% 142.67K to 152.67K | |
25-Sep-23 4:02 PM View: | Precigen, Inc. (PGEN) | 22-Sep-23 | Private Purchase | 25,000 | $1.41 | $35,250.00 | 8% 331.84K to 356.84K | |
04-May-23 10:00 PM View: | Theravance Biopharma, Inc. (TBPH) | 02-May-23 | Grant | 9,132 | -- | -- | 15% 60.89K to 70.02K | |
27-Mar-23 1:11 PM View: | Praxis Precision Medicines,... (PRAX) | 24-Mar-23 | Private Purchase | 50,000 | $0.84 | $41,815.00 | 200% 25.0K to 75.0K | |
13-Mar-23 5:11 PM View: | Precigen, Inc. (PGEN) | 09-Mar-23 | Grant | 48,290 | $1.17 | $56,499.30 | 17% 283.55K to 331.84K | |
24-Feb-23 8:07 PM View: | Precigen, Inc. (PGEN) | 22-Feb-23 | Option Exercise | 61,576 | -- | -- | 28% 221.97K to 283.55K | |
09-Jun-22 7:21 PM View: | Praxis Precision Medicines,... (PRAX) | 08-Jun-22 | Private Purchase | 25,000 | $1.81 | $45,187.50 | 100% 0 to 25.0K | |
28-Apr-22 9:04 PM View: | Theravance Biopharma, Inc. (TBPH) | 26-Apr-22 | Grant | 9,852 | -- | -- | 19% 51.03K to 60.89K | |
29-Mar-22 5:03 PM View: | Precigen, Inc. (PGEN) | 25-Mar-22 | Option Exercise | 16,212 | -- | -- | 8% 205.76K to 221.97K | |
24-Feb-22 5:49 PM View: | Precigen, Inc. (PGEN) | 22-Feb-22 | Grant | 27,832 | $2.03 | $56,499.00 | 16% 177.93K to 205.76K | |
03-Sep-21 10:00 PM View: | Immunogen Inc. (IMGN) | 03-Sep-21 | Option Exercise | 83,000 | $3.87 | $321,400.00 | 830% 10.0K to 93.0K | |
29-Apr-21 6:13 PM View: | Theravance Biopharma, Inc. (TBPH) | 27-Apr-21 | Grant | 9,828 | -- | -- | 24% 41.21K to 51.03K | |
29-Mar-21 7:48 PM View: | Precigen, Inc. (PGEN) | 25-Mar-21 | Grant | 7,328 | $7.71 | $56,498.90 | 4% 170.6K to 177.93K | (3%) |
16-Mar-21 4:33 PM View: | Precigen, Inc. (PGEN) | 13-Mar-21 | Option Exercise | 62,189 | -- | -- | 57% 108.41K to 170.6K | |
05-Mar-21 4:58 PM View: | Precigen, Inc. (PGEN) | 03-Mar-21 | Option Exercise | 2,968 | $5.69 | $16,887.90 | 3% 105.44K to 108.41K | |
23-Jun-20 4:57 PM View: | Precigen, Inc. (PGEN) | 19-Jun-20 | Option Exercise | 2,968 | $3.17 | $9,408.56 | 3% 102.47K to 105.44K | |
30-Apr-20 6:57 PM View: | Theravance Biopharma, Inc. (TBPH) | 28-Apr-20 | Grant | 6,635 | -- | -- | 19% 34.57K to 41.21K | |
17-Mar-20 6:33 PM View: | Precigen, Inc. (PGEN) | 13-Mar-20 | Grant | 28,109 | $2.01 | $56,499.10 | 38% 74.36K to 102.47K | 831% |
10-Mar-20 4:17 PM View: | Precigen, Inc. (PGEN) | 08-Mar-20 | Option Exercise | 24,703 | -- | -- | 50% 49.66K to 74.36K | |
02-May-19 6:23 PM View: | Theravance Biopharma, Inc. (TBPH) | 30-Apr-19 | Grant | 8,385 | -- | -- | 32% 26.19K to 34.57K | |
26-Mar-19 5:51 PM View: | Precigen, Inc. (PGEN) | 23-Mar-19 | Option Exercise | 7,911 | -- | -- | 19% 41.75K to 49.66K | |
12-Mar-19 7:11 PM View: | Precigen, Inc. (PGEN) | 12-Mar-19 | Option Exercise | 8,906 | $3.17 | $28,232.00 | 27% 32.84K to 41.75K | |
12-Mar-19 7:11 PM View: | Precigen, Inc. (PGEN) | 08-Mar-19 | Grant | 11,166 | $5.06 | $56,500.00 | 52% 21.68K to 32.84K | 269% |
03-May-18 6:15 PM View: | Theravance Biopharma, Inc. (TBPH) | 01-May-18 | Grant | 8,186 | -- | -- | 45% 18.0K to 26.19K | |
29-Mar-18 5:56 PM View: | Precigen, Inc. (PGEN) | 23-Mar-18 | Grant | 3,575 | $15.80 | $56,485.00 | 20% 18.1K to 21.68K | 18% |
11-Aug-17 1:03 PM View: | Precigen, Inc. (PGEN) | 11-Aug-17 | Market Purchase | 5,000 | $18.33 | $91,639.50 | 38% 13.1K to 18.1K | 2% |
18-May-17 6:03 PM View: | Theravance Biopharma, Inc. (TBPH) | 17-May-17 | Grant | 6,000 | -- | -- | 50% 12.0K to 18.0K | |
20-Mar-17 4:25 PM View: | Precigen, Inc. (PGEN) | 16-Mar-17 | Grant | 3,274 | -- | -- | 33% 9.83K to 13.1K | |
05-May-16 7:12 PM View: | Theravance Biopharma, Inc. (TBPH) | 03-May-16 | Grant | 6,000 | -- | -- | 100% 6.0K to 12.0K | |
14-Mar-16 5:35 PM View: | Precigen, Inc. (PGEN) | 10-Mar-16 | Grant | 2,000 | $34.99 | $69,980.00 | 26% 7.83K to 9.83K | (47%) |
18-Nov-15 11:13 AM View: | Immunogen Inc. (IMGN) | 17-Nov-15 | Market Purchase | 10,000 | $12.51 | $125,110.00 | 100% 0 to 10.0K | (44%) |
24-Apr-15 7:06 PM View: | Theravance Biopharma, Inc. (TBPH) | 22-Apr-15 | Grant | 6,000 | -- | -- | 100% 0 to 6.0K | |
23-Mar-15 7:02 PM View: | Precigen, Inc. (PGEN) | 12-Mar-15 | Grant | 1,474 | $47.48 | $69,985.50 | 23% 6.36K to 7.83K | (59%) |
24-Mar-14 6:50 PM View: | Precigen, Inc. (PGEN) | 20-Mar-14 | Grant | 2,278 | $30.72 | $69,980.20 | 56% 4.08K to 6.36K | (37%) |
20-Feb-14 1:55 PM View: | Precigen, Inc. (PGEN) | 18-Feb-14 | Grant | 27 | $27.68 | $747.36 | < 1% 4.05K to 4.08K | (30%) |
18-Dec-13 7:42 PM View: | Precigen, Inc. (PGEN) | 17-Dec-13 | Grant | 112 | $19.83 | $2,220.96 | 3% 3.94K to 4.05K | (2%) |
04-Nov-13 7:09 PM View: | Precigen, Inc. (PGEN) | 31-Oct-13 | Grant | 35 | $21.20 | $742.00 | < 1% 3.9K to 3.94K | (9%) |
12-Sep-13 6:51 PM View: | Precigen, Inc. (PGEN) | 10-Sep-13 | Grant | 56 | $26.76 | $1,498.56 | 1% 3.85K to 3.9K | (28%) |
15-Jun-12 4:51 PM View: | ISTA Pharmaceuticals Inc. (ISTA) | 06-Jun-12 | Disposition | 4,932 | $9.10 | $44,881.20 | (100%) 4.93K to 0 | |
03-Jun-11 2:14 PM View: | Talecris Biotherapeutics Ho... (TLCR) | 01-Jun-11 | Disposition | 3,019 | -- | -- | (100%) 3.02K to 0 | |
05-Apr-10 5:25 PM View: | Talecris Biotherapeutics Ho... (TLCR) | 01-Apr-10 | Grant | 3,019 | -- | -- | 100% 0 to 3.02K | |
31-Dec-08 8:31 PM View: | Alpharma, Inc. (ALO) | 29-Dec-08 | Disposition | 13,241 | -- | -- | (100%) 13.24K to 0 | |
12-Dec-08 4:11 PM View: | ISTA Pharmaceuticals Inc. (ISTA) | 10-Dec-08 | Grant | 2,466 | $0.00 | $2.47 | 100% 2.47K to 4.93K | 50900% |
04-Mar-08 12:15 PM View: | Alpharma, Inc. (ALO) | 29-Feb-08 | Market Purchase | 6,000 | $25.28 | $151,682.00 | 5% 114.51K to 120.51K | (72%) |
04-Mar-08 12:15 PM View: | Alpharma, Inc. (ALO) | 29-Feb-08 | Market Purchase | 1,100 | $25.09 | $27,602.00 | < 1% 120.51K to 121.61K | (72%) |
04-Mar-08 12:15 PM View: | Alpharma, Inc. (ALO) | 29-Feb-08 | Market Purchase | 2,900 | $25.25 | $73,211.40 | 264% 1.1K to 4.0K | (72%) |